Forte Biosciences, Inc. (FBRX)
NASDAQ · Healthcare
Forte Biosciences, Inc. Income Statement 2016–2019
| Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | |
|---|---|---|---|---|
| Revenues | ||||
| Revenue | 36,000 | 18.0M | 41,000 | 49,000 |
| Gross Profit | — | — | — | — |
| Profitability | ||||
| Operating Income | -4.1M | -45.9M | -37.6M | -31.7M |
| EBITDA | — | — | — | — |
| Net Income | -4.1M | -49.0M | -38.9M | -33.5M |
| Per Share Data | ||||
| EPS (diluted) | — | — | — | — |
| Shares Outstanding (dil.) | 2M | 23M | 20M | 2M |
Forte Biosciences, Inc. Income Statement — FAQ
Forte Biosciences, Inc. (FBRX) income statement over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see FBRX's income statement history?
The chart and table above show Forte Biosciences, Inc.'s income statement by year and by quarter, including the growth rate.